EMZUMAB 150MG

Emzumab 150mg combikit injection contains an active ingredient known as Emzumab 150mg combikit injection. This medication is classified as a monoclonal antibody. It is utilized for the treatment of allergic asthma, chronic rhinosinusitis (which is the inflammation of the nose and sinuses) accompanied by nasal polyps, and chronic spontaneous urticaria (CSU). It is important to inform your physician if you have an allergy to Emzumab 150mg combikit injection or any of its components, particularly if you are allergic to latex, as the syringe’s needle cap may contain latex.

Before administering Emzumab 150mg combikit injection, it is essential to consult your healthcare provider if you have any kidney or liver issues or if you are diagnosed with an autoimmune disorder. Discussing these considerations with your doctor will help ensure the safe and appropriate use of Emzumab 150mg combikit injection for your particular health condition. The safety and effectiveness of this medication in pediatric patients have not been determined. Therefore, it is advisable to consult your physician. Additionally, speak with your doctor if you are planning to conceive or suspect you may be pregnant while breastfeeding.